1 oss the cerebral hemispheres in persons with Tourette's disorder.

2 ibility reported previously in patients with Tourette's disorder.

3 were significantly greater in the group with Tourette's disorder.

4 he corpus callosum in the pathophysiology of Tourette's disorder.

5 may be an effective behavioral treatment for Tourette's disorder.

6 onal case-control study of 158 subjects with Tourette's disorder and 121 healthy comparison subjects,

7                       Changes in severity of Tourette's disorder and psychosocial impairment were inv

8 l cortical volumes in both the subjects with Tourette's disorder and the comparison subjects, but the

9     In this symptom-based factor analysis of Tourette's disorder, four factors accounted for 61% of t

10 rom childhood to age 30 years, children with Tourette's disorder had smaller overall corpus callosum

11 r to haloperidol for controlling symptoms of Tourette's disorder in children and adolescents.

12 ll corpus callosum size, whereas adults with Tourette's disorder on average had larger corpus callosu

13  the presence of heritable components of the Tourette's disorder phenotype.

14 or 61% of the phenotypic symptom variance in Tourette's disorder probands and their first-degree rela

15 ined from direct structured interviews of 85 Tourette's disorder probands.

16                     Thirty-two patients with Tourette's disorder were randomly assigned to 14 session

17 estigated the efficacy of habit reversal for Tourette's disorder, which is characterized by multiple

18 smaller corpus callosum size in persons with Tourette's disorder, which thereby limits neuronal traff

19 cted with 22 subjects, aged 7-16 years, with Tourette's disorder who were randomly assigned to first